New gel injection could ease knee arthritis pain without surgery
NCT ID NCT07489521
First seen Mar 25, 2026 · Last updated Apr 28, 2026 · Updated 5 times
Summary
This study compares a new gel-like substance (Arthrosamid®) injected into the knee joint against the standard steroid injection for treating knee osteoarthritis. The goal is to see which one better reduces pain, stiffness, and improves daily function. About 200 adults with moderate to severe knee arthritis will take part. The gel is designed to stay in the joint longer, potentially offering longer-lasting relief.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-••••
Locations
-
Cappagh National Orthopaedic Hospital
RECRUITINGDublin, Dublin, D11 EV29, Ireland
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.